SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $379,000 | -25.7% | 2,194 | -50.6% | 0.00% | 0.0% |
Q4 2014 | $510,000 | -98.7% | 4,444 | -98.2% | 0.00% | -98.5% |
Q3 2014 | $38,937,000 | -65.6% | 249,218 | -72.9% | 0.07% | -63.8% |
Q2 2014 | $113,346,000 | +7.6% | 918,907 | -9.6% | 0.18% | +6.3% |
Q1 2014 | $105,330,000 | +40.9% | 1,016,608 | +22.3% | 0.17% | +40.3% |
Q4 2013 | $74,769,000 | +24175.6% | 831,327 | +17917.5% | 0.12% | +12300.0% |
Q3 2013 | $308,000 | +1.0% | 4,614 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $305,000 | – | 4,614 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |